The Technical Analyst

Utah Medical Products Inc [UTMD]

Exchange: NASDAQ Sector: Healthcare Industry: Medical Instruments & Supplies

Utah Medical Products Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

2.01% $68.58

America/New_York / 19 apr 2024 @ 16:00

FIND ALL MARKETS FIND ALL STOCKS LISTED @ NASDAQ Live Signal Oslo Live Signal Nasdaq Live Signal Crypto

Utah Medical Products Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap:	246.13 mill
EPS:	4.57
P/E:	15.01
Earnings Date:	Apr 23, 2024
SharesOutstanding:	3.59 mill
Avg Daily Volume:	0.0300 mill

RATING 2024-04-19
A+
Strong Buy

RATINGS
Rating CashFlow:	Strong Buy
Return On Equity:	Buy
Return On Asset:	Strong Buy
DE:	Neutral
P/E:	Buy
Price To Book:	Buy

QUARTER GROWTHS
	3/22	4/22	1/23	2/23	3/23	4/23
Revenue
Gr.Profit				n/a
Ebit
Asset
Debt

PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 15.01 \| sector: PE -3.05

PE RATIO: COMPANY / INDUSTRY
0.45x
Company: PE 15.01 \| industry: PE 33.06

DISCOUNTED CASH FLOW VALUE
$119.60 (74.39%) $51.02
Date: 2024-04-20

Expected Trading Range (DAY)
$ 66.93 - 70.23 ( +/- 2.40%)
ATR Model: 14 days

Insider Trading

Date	Person	Action	Amount	type
2023-10-27	Koopman Brian	Buy	500	Employee Stock Option - Right to Buy
2023-06-15	Koopman Brian	Sell	60	Common Stock
2023-05-18	Richins Paul O	Sell	700	Common Stock
2023-03-17	Richins Paul O	Sell	150	Common Stock
2023-02-08	Payne Barbara A	Sell	500	Common Stock

INSIDER POWER
-23.87
Last 100 transactions
Buy: 7 349 \| Sell: 108 142

Forecast: 16:00 - $68.58

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $68.58

Forecast 2: 16:00 - $68.58

Forecast 3: 16:00 - $68.58

SCORE
10.00
Buy

Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022

Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD

Volume Signals
Price	$68.58 (2.01% )
Volume	0.0401 mill
Avg. Vol.	0.0300 mill
% of Avg. Vol	133.72 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Utah Medical Products Inc

Last 12 Months

RSI

Intraday RSI14 chart for Utah Medical Products Inc

Last 10 Buy & Sell Signals For UTMD

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date	Signal	@	Closed	%

UTMD

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Last 10 Buy Signals

Date	Signal	@
FUMOUSD	Apr 20 - 07:04	9 998.76
ADFUSD	Apr 20 - 07:04	0.743
42USD	Apr 20 - 06:59	51 594
WSTETHUSD	Apr 20 - 07:02	3 539.13
LEASHUSD	Apr 20 - 06:54	407.06
ORAIUSD	Apr 20 - 06:54	11.04
DIGGUSD	Apr 20 - 06:54	738.59
TRIASUSD	Apr 20 - 06:38	10.00
TKXUSD	Apr 20 - 06:34	13.33
OSHIUSD	Apr 20 - 06:23	81.71

Latest Press Releases

2024-02-06 10:00:00 - Press Release

Utah Medical Products, Inc. Announces Quarterly Dividend

Salt lake city, ut / accesswire / february 6, 2024 / utah medical products, inc. (nasdaq:utmd) announces that its board of directors approved a quarterly cash dividend of thirty cents ($.30) per share of common stock payable on april 3, 2024 to stockholders of record at the close of business on march 15, 2024. this is a 1.7% increase over the dividend declared in the same quarter of the prior year.

2024-01-30 09:00:00 - Press Release

Utmd Reports Audited Year 2023 And Fourth Quarter Financial Performance

Salt lake city, ut, jan. 30, 2024 (globe newswire) -- via newmediawire – with revenues 4% lower and net income and earnings per share 1% higher than in 2022, utah medical products, inc. (nasdaq: utmd) achieved financial results for the full year of 2023 consistent with management's beginning of year projections.

2023-10-31 10:00:00 - Press Release

Utah Medical Products, Inc. Increases Regular Quarterly Dividend

Salt lake city, ut / accesswire / october 31, 2023 / utah medical products, inc. (nasdaq:utmd) announces that its board of directors approved a quarterly cash dividend of thirty cents ($.30) per share of common stock payable on january 3, 2024 to shareholders of record at the close of business on december 15, 2023. this is a 1.7% increase over the prior regular quarterly cash dividend.

2023-10-26 09:00:00 - Press Release

Utmd Reports Financial Performance For Third Calendar Quarter And Nine Months 2023

Salt lake city, ut, oct. 26, 2023 (globe newswire) -- via newmediawire – utah medical products, inc. [nasdaq: utmd], despite a difficult third calendar quarter (3q), achieved financial results for nine months (9m) 2023 consistent with those anticipated in its beginning of year projections.

2023-08-01 10:00:00 - Press Release

Utah Medical Products, Inc. Announces Quarterly Dividend

Salt lake city, ut / accesswire / august 1, 2023 / utah medical products, inc. (nasdaq:utmd) announces that its board of directors approved a quarterly cash dividend of twenty-nine and one-half cents ($.295) per share of common stock payable on october 3, 2023 to shareholders of record at the close of business on september 15, 2023. this is a 1.7% increase over the dividend declared in the same quarter of the prior year.

Latest News

2023-09-26 01:12:18 - Seeking Alpha

Utah Medical Products: Long-Term Positives, But Filshie Clip Overhang Can't Be Ignored

Utah Medical Products stock has dropped 14% and is at its lowest point this year due to ongoing lawsuits regarding its Filshie clip system. The lawsuits do pose a risk to UTMD's stock price, and a negative outcome could further impact the company's equity. Despite the risks, UTMD's long-term economics and attractive proposition in multiple markets are bullish features.

Full Story

2023-07-14 17:56:12 - Seeking Alpha

Utah Medical Products: Earnings Power, Asset Factors Warrant Further Re-Rating

Utah Medical Products comes with high returns on capital and projected earnings growth into FY'25. The company has compounded earnings at a rate of 2.8x that of revenue since 2021. Net-net, reiterate buy, eyeing a long-term price target of $223 per share.

Full Story

2023-04-19 04:29:48 - Seeking Alpha

Utah Medical Products: Recycling Capital Well, Long-Term Gains On The Table

Full Story

2022-12-06 06:57:05 - Seeking Alpha

Is Utah Medical Products Suitable As A Defensive Overlay In Equity Portfolios?

UTMD is a relatively undercovered, unexploited name that historically trades within a narrow trading range, within a defensive sector. With this in mind, we wanted to see how it fits in within a cross-asset balanced portfolio setup.

Full Story

2021-08-03 10:00:00 - Accesswire

Utah Medical Products, Inc. Announces Quarterly Dividend

SALT LAKE CITY, UT / ACCESSWIRE / August 3, 2021 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight and one-half cents ($.285) per share of common stock payable on October 5, 2021 to shareholders of record at the close of business on September 16, 2021. This is about a 2% increase over the dividend declared in the same quarter of the prior year.

Full Story

2021-05-11 10:00:00 - Accesswire

Utah Medical Products, Inc. Announces Quarterly Dividend

SALT LAKE CITY, UT / ACCESSWIRE / May 11, 2021 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight and one-half cents ($.285) per share of common stock payable on July 6, 2021 to shareholders of record at the close of business on June 15, 2021. This is about a 2% increase over the dividend declared in the same quarter of the prior year.

Full Story

2020-10-27 09:00:00 - GlobeNewsWire

UTMD Reports Financial Performance for Third Quarter and Nine Months of Year 2020

Salt Lake City, UT, Oct. 27, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire --For the third calendar quarter (3Q) and first nine months (9M) of 2020, Utah Medical Products, Inc. (Nasdaq: UTMD) reports financial results described by CEO Kevin Cornwell as follows,

Full Story

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.